G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 26.2 PLN 4.8% Market Closed
Market Cap: 34.6m PLN
Have any thoughts about
Genomed SA?
Write Note

Genomed SA
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genomed SA
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
G
Genomed SA
WSE:GEN
Common Stock
zł132.1k
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Common Stock
zł1.6m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
5%
R
Read Gene SA
WSE:RDG
Common Stock
zł589.5k
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
B
Bioton SA
WSE:BIO
Common Stock
zł1.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
U
Urteste SA
WSE:URT
Common Stock
zł141k
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Common Stock
zł7.1m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
5%
No Stocks Found

Genomed SA
Glance View

Market Cap
34.6m PLN
Industry
Biotechnology

Genomed SA engages in the provision of medical diagnostic services. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2011-05-30. The company develops molecular diagnostics based on deoxyribonucleic acid (DNA) sequencing, with a special focus on the Next Generation Sequencing (NGS) method. The Company’s offer includes the analysis of gene mutations responsible for over 150 congenital diseases, such as infertility, predisposition to cancer, cystic fibrosis (CF), Alzheimer's disease, hearing loss, coeliac disease, cardiomyopathy and obesity, among others. The Company’s activities are directed toward introducing genomic technology to personalized medicine and creating a clinic offering gene treatments. The firm also provides diverse DNA sequencing, analysis and synthesis services for research and the biotechnological market.

GEN Intrinsic Value
25.37 PLN
Overvaluation 3%
Intrinsic Value
Price
G

See Also

What is Genomed SA's Common Stock?
Common Stock
132.1k PLN

Based on the financial report for Dec 31, 2023, Genomed SA's Common Stock amounts to 132.1k PLN.

What is Genomed SA's Common Stock growth rate?
Common Stock CAGR 5Y
0%

Over the last year, the Common Stock growth was 0%.

Back to Top